Clarus Group, Inc. Abbott Laboratories Transaction History

Clarus Group, Inc.

$258 Million
Q2 2025

A detailed history of Clarus Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Clarus Group, Inc. holds 1,637 shares of ABT stock, worth $214,332. This represents 0.09% of its overall portfolio holdings.

Number of Shares

1,637

Previous 1,859 11.94%

Holding current value

$214,332

Previous $246,000 9.76%

% of portfolio

0.09%

Previous 0.1%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 15, 2025	SELL	$123.95 - $138.08 $27,516 - $30,653	-222 Reduced 11.94%	1,637 $222,000
Q1 2025 Apr 24, 2025	SELL	$111.1 - $140.22 $249,752 - $315,214	-2,248 Reduced 54.74%	1,859 $246,000
Q4 2024 Jan 29, 2025	SELL	$111.93 - $119.39 $24,848 - $26,504	-222 Reduced 5.13%	4,107 $464,000
Q3 2023 Oct 16, 2023	SELL	$95.53 - $114.62 $35,919 - $43,097	-376 Reduced 7.99%	4,329 $419,000
Q2 2023 Jul 17, 2023	BUY	$100.78 - $112.29 $24,489 - $27,286	243 Added 5.45%	4,705 $512,000
Q1 2023 Apr 18, 2023	SELL	$96.86 - $114.01 $4,746 - $5,586	-49 Reduced 1.09%	4,462 $451,000
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $5,586 - $6,812	49 Added 1.1%	4,511 $534,000
Q4 2021 Feb 08, 2022	SELL	$115.53 - $141.46 $1,386 - $1,697	-12 Reduced 0.27%	4,462 $561,000
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $1,399 - $1,548	12 Added 0.27%	4,474 $529,000
Q1 2021 May 07, 2021	SELL	$108.84 - $128.23 $115 Million - $135 Million	-1,055,053 Reduced 99.58%	4,462 $536,000
Q1 2021 Apr 16, 2021	BUY	$108.84 - $128.23 $115 Million - $135 Million	1,055,053 Added 23645.29%	1,059,515 $7.64 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $468,510 - $510,542	4,462 New	4,462 $572,000

Others Institutions Holding ABT

# of Institutions

3,585

Shares Held

1.38B

Call Options Held

9.73M

Put Options Held

8.88M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $229B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarus Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Clarus Group, Inc. with notifications on news.

Account